Diabetes drug may improve ovarian cancer survival
Mayo Clinic Health Letter 31(6): 4
2013
ISSN/ISBN: 0741-6245 PMID: 24716275 Document Number: 670865
Document emailed within 1 workday
Related Documents
Koyama, Y.; Kurita, H.; Koike, T.; Kamata, T.; Nakanishi, Y.; Kobayashi, H. 2014: Retrospective analysis of clinical and pathological factors that influence patient survival in salivary gland cancer - could chemotherapy improve survival ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(2): 199-204Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Webb, M.J.; Malkasian, G.D.; Jorgensen, E.O. 1974: Factors influencing ovarian cancer survival after chemotherapy Obstetrics and Gynecology 44(4): 564-570
Taylor, C.G.; Sargent, J.M.; Elgie, A.W.; Williamson, C.J.; Lewandowicz, G.M.; Chappatte, O.; Hill, J.G. 2001: Chemosensitivity testing predicts survival in ovarian cancer European Journal of Gynaecological Oncology 22(4): 278-282
Whitmore, S.E. 1997: BRCA1 mutations and survival in women with ovarian cancer New England Journal of Medicine 336(17): 1254-1255; Author Reply 1256-1257
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Dumitrascu, T.; Popescu, I. 2011: Posterior approach pancreaticoduodenectomy: does it really improve long-term survival in pancreatic head cancer? Jop: Journal of the Pancreas 12(5): 491
He, X.Y.; Yuan, Y.Z. 2016: Impact of improvement of diabetes on survival after radical pancreatic resection in patients with pancreatic cancer and diabetes Zhonghua Yi Xue Za Zhi 96(16): 1270-1273
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Brightwell, R.; Eng, K.; Lele, S. 2017: Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients European Journal of Gynaecological Oncology 38(3): 378-381
Venesmaa, P. 1994: Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990 Obstetrics and Gynecology 84(1): 8-11
Markman, M. 2006: Management of ovarian cancer. An impressive history of improvement in survival and quality of life Oncology 20(4): 347-354; Discussion 354: 357-358 364 Passim
Oksefjell, H.; Sandstad, B.; Trope, C. 2006: Ovarian cancer stage IIIC. Consequences of treatment level on overall and progression-free survival European Journal of Gynaecological Oncology 27(3): 209-214
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Novikova, E.G.; Borisov, V.I.; Dmitriev, D.G.; Zel'vin, B.M.; Karseladze, A.I.; Shchitkov, K.G.; Li, A.D. 1991: Polymer-drug complexes in the treatment of extensive ovarian cancer Sovetskaia Meditsina 11: 27-29
Peters-Engl, C.; Medl, M.; Denison, U.; Sevelda, P.; Leodolter, S.; Petru, E. 2001: Does long-term application of granulocyte colony-stimulating factor adversely influence overall survival in patients with ovarian cancer? a clinical study Anticancer Research 21(5): 3701-3706
Lou, J.-y.; Peng, Z.-l.; Zheng, Y.; Wang, H.; He, B.; Wang, H.-j. 2006: Reversal of multi-drug resistance in ovarian cancer cell by RNA interference Zhonghua Fu Chan Ke Za Zhi 41(6): 413-416
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Uysal, M.; Ozdogan, M.; Kargi, A.; Gunduz, S.; Sezgin Goksu, S.; Murat Tatli, A.; Arslan, D.; Mutlu, H.; Senol Coskun, H.; Bozcuk, H. 2014: Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 980-984